Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $352,047 - $505,903
5,975 Added 45.4%
19,135 $1.18 Million
Q2 2022

Aug 11, 2022

BUY
$79.4 - $116.36 $208,742 - $305,910
2,629 Added 24.96%
13,160 $1.05 Million
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $590,680 - $750,551
6,835 Added 184.93%
10,531 $1.11 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $364,277 - $443,187
3,696 New
3,696 $398,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.